Reuters logo
BRIEF-EMA recommends suspension of marketing authorisation of Tredaptive in EU
January 11, 2013 / 12:45 PM / in 5 years

BRIEF-EMA recommends suspension of marketing authorisation of Tredaptive in EU

LONDON, Jan 11 (Reuters) * Ema assessed data related to safety concerns over tredaptive, pelzont and

trevaclyn * Ema -recommended that the marketing, supply and authorisations of these

medicines be suspended across the European union (EU).

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below